ArticlemBio2026
Cindy Menjivar, Clarissa Shoffler, Christopher Petucci, Jeffrey L Bose
Abstract read
In one paragraphArticle in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
4 authors.
Cindy MenjivarDepartment of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Clarissa ShofflerPenn Metabolomics Core, Cardiovascular Institute, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Christopher PetucciPenn Metabolomics Core, Cardiovascular Institute, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jeffrey L BoseDepartment of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.ORCID 0000-0003-3394-9557 Funding
Exogenous fatty acid utilization by Staphylococcus aureusR01AI186276 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Jeffrey Lee Bose · 2025 to 2026
$1.3MRedefining fatty acid degradation by Staphylococcus aureusR21AI153773 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BOSE, JEFFREY LEE · 2020 to 2021
$421kCharacterization of the Staphylococcus aureus fatty acid degradation pathwayF31AI181362 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MENJIVAR, CINDY · 2024 to 2025
$75kNIAID NIH HHS F31 AI181362NIAID NIH HHS R01 AI186276NIAID NIH HHS R21 AI153773
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Fatty AcidsMetabolic Networks and PathwaysStaphylococcus aureusGene DeletionGene Expression Regulation, BacterialOleic AcidOperonOxidation-ReductionPalmitic AcidFatty AcidsOleic AcidPalmitic Acidfatty acidmetabolismMRSAβ-oxidation
Identifiers
PMID42003618
PMCPMC13170264
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390